Alta Bates Medical Center Cancer Center

Berkeley, California 94705

1 studies enrolling now · 2 studies all time

What they study most

Ischemic Stroke; Ischemic Attack, Transient, Multiple Myeloma

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)